UCB SA (UCBJY)
64.43
-0.06
(-0.10%)
USD |
OTCM |
May 07, 15:56
UCB Price to Book Value: 2.465 for May 7, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 2.467 |
| May 03, 2024 | 2.482 |
| May 02, 2024 | 2.509 |
| May 01, 2024 | 2.550 |
| April 30, 2024 | 2.534 |
| April 29, 2024 | 2.527 |
| April 26, 2024 | 2.543 |
| April 25, 2024 | 2.575 |
| April 24, 2024 | 2.479 |
| April 23, 2024 | 2.497 |
| April 22, 2024 | 2.484 |
| April 19, 2024 | 2.469 |
| April 18, 2024 | 2.436 |
| April 17, 2024 | 2.451 |
| April 16, 2024 | 2.422 |
| April 15, 2024 | 2.410 |
| April 12, 2024 | 2.444 |
| April 11, 2024 | 2.412 |
| April 10, 2024 | 2.370 |
| April 09, 2024 | 2.364 |
| April 08, 2024 | 2.377 |
| April 05, 2024 | 2.365 |
| April 04, 2024 | 2.382 |
| April 03, 2024 | 2.378 |
| April 02, 2024 | 2.360 |
| Date | Value |
|---|---|
| April 01, 2024 | 2.350 |
| March 28, 2024 | 2.357 |
| March 27, 2024 | 2.356 |
| March 26, 2024 | 2.367 |
| March 25, 2024 | 2.389 |
| March 22, 2024 | 2.363 |
| March 21, 2024 | 2.314 |
| March 20, 2024 | 2.250 |
| March 19, 2024 | 2.245 |
| March 18, 2024 | 2.227 |
| March 15, 2024 | 2.181 |
| March 14, 2024 | 2.220 |
| March 13, 2024 | 2.240 |
| March 12, 2024 | 2.262 |
| March 11, 2024 | 2.273 |
| March 08, 2024 | 2.296 |
| March 07, 2024 | 2.297 |
| March 06, 2024 | 2.273 |
| March 05, 2024 | 2.208 |
| March 04, 2024 | 2.244 |
| March 01, 2024 | 2.255 |
| February 29, 2024 | 2.202 |
| February 28, 2024 | 2.178 |
| February 27, 2024 | 2.020 |
| February 26, 2024 | 1.999 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.347
Minimum
Sep 22 2022
3.224
Maximum
Jul 30 2020
2.040
Average
2.025
Median
Mar 09 2021
Price to Book Value Benchmarks
| Galapagos NV | 0.6134 |
| Mithra Pharmaceuticals SA | -- |
| Nyxoah SA | 2.488 |
| Celyad Oncology SA | -- |
| MDxHealth SA | -- |
Price to Book Value Related Metrics
| PE Ratio | 67.22 |
| PS Ratio | 4.419 |
| Price to Free Cash Flow | 52.35 |
| Price | 64.43 |
| Earnings Yield | 1.49% |
| Market Cap | 24.45B |
| Operating PE Ratio | 36.54 |
| Normalized PE Ratio | 67.53 |